Whalesbook
Specialty Medicine ka naya trend
Brokers ka kehna hai ki Indian pharma companies ab sirf generic drugs se aage badh rahi hain. Wo ab complex injectables, peptide therapies aur biosimilars par zyada focus kar rahi hain. Aisa karne se unhe price erosion se bachne mein help milegi. Sun Pharmaceutical Industries aur Neuland Laboratories jaisi companies apni margins ko volatile pricing se bachane ki koshish kar rahi hain.
International Market mein dhamaka
Companies sirf India mein hi nahi, balki international market mein bhi bade acquisitions kar rahi hain. US market mein $11.75 billion ka ek bada deal hua hai, jo dikhata hai ki companies apni balance sheets ko leverage kar rahi hain. Isse unhe US mein manufacturing capacity mil rahi hai aur revenue streams bhi diversify ho rahe hain. Indian market ke fluctuations se alag, ye companies apna 30% se 50% revenue international operations se generate karti hain, jo ek accha hedge hai.
Risks bhi hain bhai!
Lekin sab kuch itna smooth nahi hai. US FDA ki inspections ek bada risk hain. Agar koi negative observation ya warning letter aaya, toh supply chain mein problem aa sakti hai aur earnings bhi kam ho sakti hain. Saath hi, domestic market mein National List of Essential Medicines ke karan pricing mein zyada flexibility nahi hai.
Alembic Pharmaceuticals aur GlaxoSmithKline Pharmaceuticals jaisi companies ko transition mein execution risk ka saamna karna pad sakta hai. Indegene jaisi companies jo asset-light model par hain, unko bhi life sciences spending cuts ka khatra hai. Currency fluctuations bhi ek double-edged sword hain; dollar revenue mein hone ke bawajood, complete hedging na hone se reporting mein volatility aa sakti hai.
Market ka Outlook
Brokerages ka kehna hai ki quality-focused companies achha perform karengi. Jo companies AI-driven commercialization services aur complex chemical manufacturing use kar rahi hain, unki valuation bhi zyada hai. Forecasted 28% upside tabhi milega jab regulatory audits successful honge aur specialty segment mein pricing power maintain rahegi.